FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Fortesta Not Withdrawn Due to Safety/Efficacy

[ Price : $8.95]

Federal Register notice: FDA determines that Endos Fortesta (testosterone) gel was not withdrawn due to safety or effectiveness re...

Third-Party Review Guidance

[ Price : $8.95]

FDA publishes a guidance with information on third-party review of 510(k)s and emergency use authorizations.

New DTC Major Statement Standards Become Effective

[ Price : $8.95]

New FDA advertising standards require drug marketers to ensure their direct-to-consumer advertisements major statement is presente...

Preserve Covid-19 Vaccine Records: Senator

[ Price : $8.95]

Republican Sen. Ron Johnson orders FDA, HHS, and CDC to preserve all records relating to Covid-19 vaccines, saying they will be su...

CDER Deputy Throckmorton Retiring in January

[ Price : $8.95]

CDER deputy director for regulatory programs Doug Throckmorton announces his retirement after 27 years at the agency.

FDA Revokes EUAs on Covid Tests

[ Price : $8.95]

Federal Register notice: FDA revokes the Emergency Use Authorizations issued to Cue Health for the Cue Covid19 Test, and Cue Covid...

FDA Provides More Draft ANDA-Specific Guidances

[ Price : $8.95]

Federal Register notice: FDA makes available additional draft and revised draft product-specific guidances for generic drug sponso...

Fludarabine Phosphate Labeling Changes OKd

[ Price : $8.95]

FDA announces approved labeling changes for Sandoz fludarabine phosphate injection under the Oncology Center of Excellences Projec...

FDA Clears Ultromics EchoGo Amyloidosis Device

[ Price : $8.95]

FDA clears an Ultromics 510(k) for the EchoGo Amyloidosis for detecting cardiac amyloidosis.

Sage Ending Dalzanemdor Development

[ Price : $8.95]

Sage says it is ending dalzanemdor development in Huntingtons disease cognitive impairment following Phase 2 DIMENSION results tha...